07:40 a.m. - 08:00 a.m.
Update on Epidemiology and Nomenclature
Sharon J. Parish, MD, IF, NCMP

08:00 a.m. - 08:25 a.m.
Sexual Health Interview
Sharon J. Parish, MD, IF, NCMP

08:25 a.m. - 08:40 a.m.
Physical Exam
Tami Rowen, MD, MS, IF

08:40 a.m. - 09:10 a.m.
Testing Procedures; Hormonal, Vascular, Neurologic
Irwin Goldstein, MD, IF

09:10 a.m. - 09:40 a.m.
Non-Hormonal Pharmacologic Treatments
Irwin Goldstein, MD, IF

09:40 a.m. - 09:55 a.m.
Sexual Dysfunction and Depression; Treatment Considerations
Sharon J. Parish, MD, IF, NCMP

10:15 a.m. - 10:40 a.m.
Hormonal Treatment; Estrogens and Progestogens
Tami Rowen, MD, MS, IF

10:40 a.m. - 10:55 a.m.
Hormonal Treatment; Androgens
Sharon J. Parish, MD, IF, NCMP

10:55 a.m. - 11:15 a.m.
Painful Intercourse: Causes, Evaluation and Treatment
Irwin Goldstein, MD, IF

11:15 a.m. - 11:35 a.m.
Vestibulodynia: Diagnosis and Treatment
Irwin Goldstein, MD, IF

11:35 a.m. - 11:50 a.m.
Treatment Options for GSM
Tami Rowen, MD, MS, IF

Irwin Goldstein, MD, IF

Stanley E. Althof, PhD, IF, Sheryl A. Kingsberg, PhD, IF & Michael A. Perelman, PhD, IF

Sexual Activity Changes Patterns of Inflammation in Healthy Women (#001)
T. Lorenz

Digital Cervicography for Quality Control of Visualization With Acetic Acid (VIA) for Cervical Dysplasia Screening (#002)
L. Goldstein

Cardiometabolic Risk and Female Sexuality: Focus on Clitoral Vascular Resistance (#003)
L. Vignozzi

The Role of Interoception in Women's Perception of their Arousal (#004)
A. Handy

Neural Networks Underlying Variants of Female Sexual Dysfunction (#005)
Melissa A. Farmer, PhD

Improvements in Acute Subjective Sexual Arousal after a Brief Session of Autogenic Training in Women with Sexual Arousal Problems (#006)
A.M. Stanton

Safety and Efficacy of High Intensity Focused Ultrasound (HIFU) treatment for vagina Ultra Vera - Preliminary results (#007)
Y. Sekiguchi

Effectiveness of a Novel Technology on Women's Urogenital Health and Sexual Function (#008)
S. de la Torre

Vaginal Mechanically-Triggered ATP Signaling is Impaired in Diabetic Mice (#009)
J.E. Harroche

03:30 p.m. - 04:00 p.m.
Psychological Consequences of Sexual Trauma
Alessandra Rellini, PhD

04:00 p.m. - 04:30 p.m.
Optimizing Trauma Informed Care for Refugee Women Impacted by Sexual and Gender-Based Violence
Crista E. Johnson-Agbakwu, MD, MSc, IF

04:30 p.m. - 05:00 p.m.
Pharmacotherapy for PTSD and its Comorbidities
Stephen M. Stahl, MD, PhD

Stephen W. Porges, PhD

08:00 a.m. - 08:30 a.m.
Health Correlates of Estrogen Delivery Methods
James A. Simon, MD, CCD, NCMP, IF, FACOG

08:30 a.m. - 09:00 a.m.
Diagnosis of Sexual Desire & Arousal Disorder
Anita H. Clayton, MD, IF

09:00 a.m. - 09:30 a.m.
Advances in Vulvodynia
Andrew T. Goldstein, MD, IF, FACOG

09:30 a.m. - 10:00 a.m.
Visceral Manipulation Approach
Dee Hartmann, PT, DPT

10:00 a.m. - 10:30 a.m.
Pain Science-Based Manual Therapy Approach
Sandy Hilton, PT, DPT, MS

Allan Basbaum, PhD

Kathryn E. Flynn, PhD & Shari Goldfarb, MD

Tami Rowen, MD, MS, IF

Alan W. Shindel, MD

Melissa Feldhaus-Dahir, DNP, IF & Michael Policar, MD, MPH

A Team-based Model of Care for Management of Female Sexual Dysfunction (#010)
S. Faubion

Behavioral Measures for Clinical Trials of Women with Decreased Sexual Desire (#011)
R. Pyke

Flibanserin in Premenopausal Women With Hypoactive Sexual Desire Disorder: A Responder Analysis of Randomized Placebo-Controlled Studies (#012)
James A. Simon, MD, CCD, NCMP, IF, FACOG

Product Acceptability and Women’s Satisfaction with a Low-dose Solubilized Vaginal Estradiol Softgel Capsule, TX-004H (#013)
Sheryl A. Kingsberg, PhD, IF

The Effects of RF Excited Fractional CO2 Laser for the Treatment of Stress Urinary Incontinence (#014)
F. Patel

Combined Data of Intravaginal Prasterone against Vulvovaginal Atrophy of Menopause (#015)
F. Labrie

Changes in Arousal and Desire in the Bremelanotide RECONNECT Study (#016)
L. DeRogatis

Bremelanotide (BMT) for Hypoactive Sexual Desire Disorder (HSDD) in the RECONNECT Study: Efficacy Analyses in Study Completers and Responders (#017)
James A. Simon, MD, CCD, NCMP, IF, FACOG

A Prospective Multicentre Randomised Controlled Trial of Quality of Life and Sexual Satisfaction Comparing Clinician assisted Pelvic Floor Exercises with PeriCoach assisted Pelvic Floor Exercises in the Management of Female Stress Urinary Incontinence (#018)
P. Castillo

Together we are Strong
Annamaria Giraldi, MD, PhD, IF

04:00 p.m. - 04:25 p.m.
ISSWSH Nomenclature Process and ICD-11
Sharon J. Parish, MD, IF, NCMP

04:25 p.m. - 04:31 p.m.
Background
Sue Goldstein, BA, IF

04:31 p.m. - 04:37 p.m.
Sexual Desire
James G. Pfaus, PhD

04:37 p.m. - 04:43 p.m.
Sexual Arousal
Andrew T. Goldstein, MD, IF, FACOG

04:43 p.m. - 04:49 p.m.
Orgasm
Irwin Goldstein, MD, IF

04:49 p.m. - 05:00 p.m.
Q&A

06:00 a.m. - 06:05 a.m.
Introduction
Linda M. Cataldo

06:05 a.m. - 06:10 a.m.
Memorial for those with PGAD who have lost their lives to this disease

06:10 a.m. - 06:40 a.m.
PGAD Research Study
Caroline F. Pukall, PhD, CPsych, Barry R. Komisaruk, PhD & Lisa Squibb

06:40 a.m. - 06:50 a.m.
PGAD Conceptualization
Sue Goldstein, BA, IF

06:50 a.m. - 07:10 a.m.
PGAD Research
James G. Pfaus, PhD & Marcel D. Waldinger, MD, PhD

07:10 a.m. - 07:20 a.m.
PGAD Psychologic Factors
Eveline Poirier

07:20 a.m. - 07:30 a.m.
PGAD in a Vulvovaginal Disorders Specialty
Andrew T. Goldstein, MD, IF, FACOG

07:30 a.m. - 07:40 a.m.
PGAD in Men - Special Concerns
Shan Bokhari

07:40 a.m. - 07:50 a.m.
Pelvic Floor
Karen Brandon

07:50 a.m. - 08:00 a.m.
PGAD in Special Populations - Children, Adolecents, Pregnancy and Breast Feeding
Sherita King, MD

Barry R. Komisaruk, PhD

09:00 a.m. - 09:30 a.m.
Altering Sexual Anticipation with Brain Stimulation
Nicole Prause, PhD

09:30 a.m. - 10:00 a.m.
The Connected Brain: Relevance to Sexual Behavior
Janniko R. Georgiadis, PhD

10:00 a.m. - 10:30 a.m.
Sexual Trance and Orgasm
Adam Safron, MS

Murray Freedman, MD, IF & Risa Kagan, MD

The Perceived Effects of Marijuana Use Before Sex (#019)
B. Lynn

The Joy of (Lots of Different Types of) Sex: Factors Associated with Sexual Pleasure (#020)
J.L. Warmann

Sexual Communication and Risky Sexual Practices and Perceptions among University Students from Lebanon (#021)
F. El Kak

The Importance of the Developmental Stage of Nonconsensual Sexual Experiences in Women's Sexual Adjustment (#022)
C.D. Kilimnik

Reflections of Women Successfully Treated by Flibanserin at a Single Center (#023)
Sue Goldstein, BA, IF

Motivations for Sexual Intercourse among Women with a History of Childhood Sexual Abuse (#024)
C. Pulverman

Comparison of Sexual Satisfaction between Transgender Volunteers and Individuals who Underwent Transgender Operation (#025)
S. Behzadi Pour

Review of Urinary Incontinence and Associated Female Sexual Dysfunction (#026)
E.R. Duralde

New Position Statement on Hormone Therapy
Marla Shapiro, CM, MDCM, CCFP, MHSC, FRCPC, FCFP, NCMP 

The Relationship Between Death-Anxiety and Sexual Behavior in Women
Daniel N. Watter, EdD

03:30 p.m. - 04:00 p.m.
Clinical Assessment
Irwin Goldstein, MD, IF

04:00 p.m. - 04:30 p.m.
Theoretical Mechanisms
James G. Pfaus, PhD

04:30 p.m. - 05:00 p.m.
Pain Assessment
Caroline F. Pukall, PhD, CPsych

Lauren Streicher, MD

Perceived Genital Arousal in Women with Sexual Dysfunction (#037)
A. Handy

Peri-Clitoral Botulinum Toxin as a Treatment for Persistent Genital Arousal Disorder (PGAD) (#038)
R.S. Rubin

Reliability and Validity of the Elements of Desire Questionnaire in the Bremelanotide RECONNECT study (#039)
D.A. Revicki

Self-Reported Sexual Problems are Higher in Breast Cancer vs. Non Breast Cancer Patients (#040)
M. Hughes

The Relationship between Physiological Genital Arousal and Genital Sensations in Women (#041)
A. Handy

An Association between the Pain Domain of the Female Sexual Function Index (FSFI) and Its Other Domains in Postmenopausal Women with Vulvar and Vaginal Atrophy (#045)
Sheryl A. Kingsberg, PhD, IF

Cervical Ectropion may be a Cause of Desquamative Inflammatory Vaginitis (#046)
M. King

Responder Values for Clinical Trials in Female Sexual Interest/Arousal Disorder (#047)
R. Pyke

Effects of Fractional Microablative CO2 Laser Therapy on Sexual Function and the Symptoms of the Genitourinary Syndrome of Menopause (#048)
P.A. Gittens

Remitter Cutoffs for Clinical Trials in Female Sexual Interest/Arousal Disorder (#049)
R. Pyke

The Relationship Between Sexual Shame and Sexual Self-Schemas in College Women (#050)
G. del Rey

A Comparison of Attachment Styles and Identity Styles in People with Gender Dysphoria Disorder (Operated and Not Operated) and Normal People (#051)
S. Behzadi Pour

Clitorodynia in a Pediatric Patient: Lysis of Clitoral Adhesions Following Dorsal Nerve Block (#052)
Sherita King, MD

The Complexities of Persistent Genital Arousal Disorder (PGAD) (#053)
Eveline Poirier

Moral Foundations as a Predictor of Internalized Homophobia and Homophobia among Bisexual Women (#054)
J.L. Warmann

The Role of Attachment Styles, and Parental Bonding in Sexual Addiction (#055)
S. Behzadi Pour

Prevalence of Persistent Genital Arousal Disorder Criteria in a Sample of Canadian Undergraduate Students (#056)
R. Jackowich

The Efficiency of Marital and Sexual Skill Training on Hypoactive Sexual Desire and Marital Satisfaction in Women (#057)
S. Behzadi Pour

Craving the Catcalls: Psychosexual Correlates of the Enjoyment of Sexualization (#058)
J.L. Warmann

Health Care Experiences of Women with Symptoms of Persistent Genital Arousal (#059)
R. Jackowich

Psychological and Sexual Correlates of Sexual Abuse in Women with Sexual Dysfunction (#060)
L. Vignozzi

The Role of Sexual Schemas in the Body Appraisals and Sexual Functioning of Women with Nonconsensual Sexual Experiences (#061)
C.D. Kilimnik

Comparison oEarly Maladaptive Schemas and Attachment Styles in Women with Vaginismus and Normal Women (#062)
S. Behzadi Pour

Sexual Activity Recommendations in High Risk Pregnancies (#063)
K. Konys

Characteristics of Hypoactive Sexual Desire Disorder Women who visited Community Gynecology Hospital for Consulting Sexual Dysfunction (#027)
H. Yun

A Systematic Review of Sexual Function in Adolescents and Young Adults Diagnosed with Cancer (#028)
A.M. Stanton

Prevalence of Clitoral Adhesions in a Sexual Medicine Practice: Retrospective Vulvoscopy Review (#029)
L. Aerts

Anatomic Sites and Risk Factors for Deep Dyspareunia (#030)
P. Yong

Outpatient Complete Vestibulectomy for Neuro-Proliferative Vestibulodynia: Review of Technique (#031)
R.S. Rubin

Standardized Step-Wise Approach to Vulvoscopy to Maximize Diagnostic Yield (#032)
A.G. Winter

In Office Treatment of Clitorodynia: Lysis of Clitoral Adhesions to Adjacent Skin Following Dorsal Nerve Block (#033)
R.S. Rubin

Fractional CO2 Laser Treatment for the Symptoms of Genitourinary Syndrome of Menopause (#034)
M.A. Garcia

Improvement in Female Sexual Function using Co2 Laser Therapy (#035)
M. Sophocles

Vulvar Vestibulectomy for Neuroproliferative Associated Vestibulodynia: A Retrospective Case-Control Study (#036)
M. King

Annamaria Giraldi, MD, PhD, IF, Sharon J. Parish, MD, IF, NCMP & Lauren Streicher, MD